James K. Hogan

Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.

David H.‐F. Teng, William L. Perry, James K. Hogan et al. · PubMed · 1997 · 193 citations

Life Sciences, Cell Biology, Molecular Biology +13

Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases

Luc J. Farmer, Mark W. Ledeboer, Thomas Hoock et al. · Journal of Medicinal Chemistry · 2015 · 89 citations

Medicine, Medicinal Chemistry, Pharmacology +13

The Marine Cyanobacterial Metabolite Gallinamide A Is a Potent and Selective Inhibitor of Human Cathepsin L

Bailey W. Miller, Aaron J. Friedman, Hyukjae Choi et al. · Journal of Natural Products · 2013 · 76 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Investigation of protein refolding using a fractional factorial screen: A study of reagent effects and interactions

Melissa Swope Willis, James K. Hogan, Prakash Prabhakar et al. · Protein Science · 2005 · 75 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +11

VX-509 (Decernotinib) Is a Potent and Selective Janus Kinase 3 Inhibitor That Attenuates Inflammation in Animal Models of Autoimmune Disease

Sudipta Mahajan, James K. Hogan, Dina Shlyakhter et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 60 citations

Medicine, Immunology, Pharmacology +16